Found 0 matching trials
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China PHASE3 The study is to evaluate immune response induced by 9-valent HPV study vacc...
Show More Status
Active Not Recruiting
Location
Yunnan Center for Disease Prevention and Control
Learn More & Join Trial
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents PHASE3 Primary Objective:
To demonstrate the non-inferiority of the seroprotectio...
Show More Location
Investigational Site Number :3480003
Learn More & Join Trial
Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand NA This is a community intervention effectiveness study in female school stude...
Show More Location
Ministry of Public Health
Learn More & Join Trial
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 NA Randomized, 2-arm observational study. The 2 arms (randomized at the level ...
Show More Location
Eskenazi Health Outpatient Care Center
Learn More & Join Trial
Immunogenicity and Safety of One Dose of HPV Vaccine PHASE4 This study will assess the immunogenicity and safety of one dose of Cecolin...
Show More Location
Fujian Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico PHASE4 In September 2009 the National Vaccination Council approved the policy for ...
Show More Location
Centro Médico Cuauhtemoc
Learn More & Join Trial
Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064) PHASE3 The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Show More Location
Umeyama Clinic ( Site 6406)
Learn More & Join Trial
HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) NA This intervention study will use parent-, provider-, and health center-leve...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination PHASE3 A research project is currently being undertaken looking at Human Papilloma...
Show More Location
Royal Childrens Hospital
Learn More & Join Trial
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial